Testosterone enhances estradiol's cardioprotection in ovariectomized rats

Journal of Endocrinology

Volumn 212, Issue 1, 2012, Pages 61-69

  Liu, Aiying ^a   Gao, Liping ^a   Kang, Shoulei ^a   Liu, Ying ^a   Xu, Chuanying ^a   Sun, Hong ^a   Li, Dongye ^a   Yan, Changdong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; ESTRADIOL; LACTATE DEHYDROGENASE; TESTOSTERONE;

ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MUSCLE CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; L-LACTATE DEHYDROGENASE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OVARIECTOMY; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-2; TESTOSTERONE; UP-REGULATION;

EID: 83455224739     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0181     Document Type: Article

References (36)

1. Bhupathy P, Haines CD & Leinwand LA 2010 Influence of sex hormones and phytoestrogens on heart disease in men and women. Women's Health 6 77-95.
2. Booth EA & Lucchesi BR 2008 Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovascular Toxicology 3 101-113.
3. Bourghardt J, Wilhelmson AS, Alexanderson C, De Gendt K, Verhoeven G, Krettek A, Ohlsson C & Tivesten A 2010 Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151 5428-5437.
4. Callies F, Strömer H, Schwinger RH, Bölck B, Hu K, Frantz S, Leupold A, Beer S, Allolio B & Bonz AW 2003 Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinolgy 44 4478-4483.
5. Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA & SnabesMC 1997 Effect of postmenopausal estrogen replacement on circulating androgens. Obstetrics and Gynecology 90 995-998.
6. Cavasin MA, Sankey SS, Yu AL, Menon S & Yang XP 2003 Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 284 H1560-H1569.
7. Das B & Sarkar C 2006 Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. Journal of Cardiovascular Pharmacology 47 277-286.
8. Das A, Smolenski A, Lohmann SM & Kukreja RC 2006 Cyclic GMPdependent protein kinase I alpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte. Journal of Biological Chemistry 281 38644-38652.
9. Hao Y, Sun Y, Xu C, Jiang X, Sun H, Wu Q, Yan C & Gu S 2009 Improvement of contractile function in isolated cardiomyocytes from ischemia-reperfusion rats by ginkgolide B pretreatment. Journal of Cardiovascular Pharmacology 54 3-9.
10. Iellamo F, Volterrani M, Caminiti G, Karam R, Massaro R, Fini M, Collins P & Rosano GM 2010 Testosterone therapy in women with chronic heart failure. A pilot double-blind, randomized, placebo-controlled study. Journal of the American College of Cardiology 56 1310-1316.
11. Liou CM, Yang AL, Kuo CH, Tin H, Huang CY & Lee SD 2010 Effects of 17beta-estradiol on cardiac apoptosis in ovariectomized rats. Cell Biochemistry and Function 28 521-528.
12. Lizotte E, Grandy SA, Tremblay A, Allen BG & Fiset C 2009 Expression, distribution and regulation of sex steroid hormone receptors in mouse heart. Cellular Physiology and Biochemistry 23 75-86.
13. Lucchinetti E, Jamnicki M, Fischer G & Zaugg M 2008 Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesthesia and Analgesia 106 17-23.
14. Luczak ED & Leinwand LA 2009 Sex-based cardiac physiology. Annual Review of Physiology 71 1-18.
15. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F & Pujia A 2007 Endogenous testosterone and endothelial function in postmenopausal women. Coronary Artery Disease 18 9-13.
16. Nordmeyer J, Eder S, Mahmoodzadeh S, Martus P, Fielitz J, Bass J, Bethke N, Zurbrügg HR, Pregla R, Hetzer R et al. 2004 Upregulation of myocardial estrogen receptors in human aortic stenosis. Circulation 110 3270-3275.
17. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C et al. 2004 17beta-estradiol reduces cardiomyocyte apoptosis in vivo via activation of phospho-inositide-3 kinase/Akt signaling. Circulation Research 95 692-699.
18. Ren J, Hintz KK, Roughead ZK, Duan J, Colligan PB, Ren BH, Lee KJ & Zeng H 2003 Impact of estrogen replacement on ventricular myocyte contractile function and protein kinase B/Akt activation. American Journal of Physiology. Heart and Circulatory Physiology 284 H1800-H1807.
19. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Heatlh Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333.
20. Sánchez-Más J, Turpin MC, Lax A, Ruipérez JA, Valdés Chávarri M & Pascual-Figal DA 2010 Differential actions of eplerenone and spironolactone on the protective effect of testosterone against cardiomyocyte apoptosis in vitro. Revista Española de Cardiología 63 779-787.
21. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S et al. 2006 Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 13 770-779.
22. Shifren JL, Desindes S, Mcllwain M, Doros G & Mazer NA 2007 A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause 14 985-994.
23. Sievers C, Klotsche J, Pieper L, Schneider HJ, Marz W, Wittchen HU, Stalla GK &Mantzoros C 2010 Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. European Journal of Endocrinology 163 699-708.
24. Simpson ER 2002 Aromatization of androgens in women: current concepts and findings. Fertility and Sterility 77 S6-S10.
25. Sun H, Zhou F, Wang Y, Zhang Y, Chang AM & Chen Q 2006 Effects of β-adrenoceptors overexpression on cell survival are mediated by Bax/Bcl-2 pathway in rat cardiac myocytes. Pharmacology 78 98-104.
26. Tsang S, Wu S, Liu J &Wong TM 2008 Testosterone protects rat hearts against ischemic insults by enhancing the effects of α1-adrenoceptor stimulation. British Journal of Pharmacology 153 693-709.
27. Tsang S, Wong SS, Wu S, Kravtsov GM & Wong TM 2009 Testosteroneaugmented contractile responses to α1- and β1-adrenoceptor stimulation are associated with increased activities of RyR, SERCA, and NCX in the heart. American Journal of Physiology. Cell Physiology 296 C766-C782.
28. Vicencio JM, Ibarra C, Estrada M, Chiong M, Soto D, Parra V, Diaz-Araya G, Jaimovich E & Lavandero S 2006 Testosterone induces an intracellular calcium increase by a nongenomic mechanism in cultured rat cardiac myocytes. Endocrinology 147 1386-1395.
29. Vickers MR, Maclennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC et al. 2007 Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 335 239-244.
30. Wu Q, Zhao Z, Sun H, Hao YL, Yan CD & Gu SL 2008 Estrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischemia-reperfusion. Experimental Physiology 93 1034-1043.
31. Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG & Han Q 2006 Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends in Pharmacological Sciences 6 330-337.
32. Xin HB, Senbonmatsu T, Cheng DS, Wang YX, Copello JA, Ji GJ, Collier ML, Deng KY, Jeyakumar LH, Magnuson MA et al. 2002 Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 6878 334-338.
33. Xu X, De Pergola G & Bjorntorp P 1991 Testosterone increases lipolysis and the number β-adrenoreceptors in male rat adipocytes. Endocrinology 128 379-381.
34. 2-Adrenoceptor confers cardioprotection against hypoxia in isolated ventricular myocytes and the effects depend on estrogenic environment. Journal of Receptors and Signal Transduction Research 30 255-261.
35. Zhang L, Wu S, Ruan Y, Hong L, Xing X & Lai W 2011 Testosterone suppresses oxidative stress via androgen receptor-independent pathway in murine cardiomyocytes. Molecular Medicine Reports 4 1183-1188.
36. 2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circulation Research 97 507-509.